SCHEMBL5149376

SCHEMBL5149376

CC(C)c1cccc(-c2cccc(C(=O)N[C@@H](CO)Cc3c[nH]c4ccccc34)c2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 2/20 0.53
CCND1 P24385 2/20 0.53
HPGDS O60760 1/20 0.51
ECE1 P42892 1/20 0.51
ERAP2 Q6P179 1/20 0.50
CTSL P07711 1/20 0.49
TACR1 P25103 6/20 0.48
MEN1 O00255 1/20 0.48
POLB P06746 1/20 0.48
HTT P42858 1/20 0.48
KMT2A Q03164 1/20 0.48
ITGB2 P05107 2/20 0.48
ICAM1 P05362 2/20 0.48
ITGAL P20701 2/20 0.48
HDAC3 O15379 1/20 0.47
HDAC4 P56524 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC7 Q8WUI4 1/20 0.47
HDAC2 Q92769 1/20 0.47
HDAC10 Q969S8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5151665 0.94 HPGDS (0.58) CDK4CCND1HPGDSECE1ERAP2
SCHEMBL5155616 0.90 ERAP2 (0.47) CDK4CCND1HPGDSECE1ERAP2
SCHEMBL5149264 0.90 ERAP2 (0.47) CDK4CCND1HPGDSECE1ERAP2
SCHEMBL5149438 0.88 CDK4 (0.52) CDK4CCND1ECE1MEN1POLB
SCHEMBL4601988 0.85 CDK4 (0.57) CDK4CCND1HPGDSERAP2CTSL
SCHEMBL5151298 0.85 POLB (0.47) HPGDSECE1MEN1POLBHTT
SCHEMBL13902827 0.85 TACR1 (0.55) CDK4CCND1ECE1ERAP2CTSL
SCHEMBL4601301 0.85 KMT2A (0.58) CDK4CCND1HPGDSERAP2TACR1
SCHEMBL5152158 0.85 KMT2A (0.58) CDK4CCND1HPGDSERAP2TACR1
SCHEMBL5149333 0.84 CDK4 (0.53) CDK4CCND1HPGDSERAP2CTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US claimed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060573-A1 Acyltryptophanols FSHR, NPY1R, NPY2R CDK4 4400/4885CCND1 592/4885HPGDS 1308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.